Solutions For The Clinical-Grade Manufacturing Of Gene-Engineered Natural Killer (NK) Cells

Natural killer (NK) cells are a type of cytotoxic innate lymphocyte that play a crucial role in the immune system by directly recognizing and eliminating cells infected by viruses or those that have become malignant. In this webinar, delve into the methodologies for efficiently manufacturing gene-engineered NK cells for clinical applications as well as cover strategies for scaling up the production of NK cells to meet clinical demands. Standardizing the in-process control (IPC) and quality control (QC) steps is crucial to maintaining consistency and high quality throughout the manufacturing process.

Discover a comprehensive approach that aims to advance the application of NK cells in therapeutic settings to ensure that they are produced reliably and effectively for patient treatments.